Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	1/21/2005 9:25:53 AM
	Read Replies (2) of 946

[Supposed to be] From Briefing.com. [I have not been able to verify the source, but the pre-market activity is strong today]. 09:13 CTIC Cell Therapeutics: Stock could double in the next 2-3 months - WR Hambrecht (8.11 ) WR Hambrecht believes that CTIC could double or more in the next 2-3 months. Firm expects data from the Phase III STELLAR 3 trial of Xyotax in 1st line lung cancer patients in late-March or early-April. Firm's expectation is for a statistically significant survival advantage over Taxol. However, they believe more modest results could also offer a viable regulatory path. Their bullish outlook is enhanced by a relatively large short position and a likely well-entrenched negative bias against the co among many investors

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next